Company news: Physicians Interactive, WorldOne, Bristol-Myers Squibb and Inhibitex

Share this article:

Physicians Interactive (PI) and WorldOne formed an exclusive strategic alliance to merge their US-based healthcare marketing research panels, firms said. The panel includes 300,000+ AMA-verified physicians amid a network of online and mobile HCPs spanning about a million physicians, nurses and allied health professionals in all major specialties, PI and WorldOne said. The alliance will enable HCPs to share insights with life science firms, market research organizations, academic centers and associations.

Bristol-Myers Squibb said it is buying hepatitis C drug developer Inhibitex for about $2.5 billion. The deal comes a few months before the patent is set to expire on BMS's biggest-selling drug, antiplatelet agent Plavix, and gives BMS access to Inhibitex's potential HCV drug INX-189. In November Gilead Sciences struck a $10.8 billion deal to buy experimental hepatitis C drug maker Pharmasset.

Share this article:

Email Newsletters

More in Business Briefs

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

AbbVie's files all-oral HCV drug with FDA

AbbVie's all-oral HCV treatment filed off six Phase-III trials spanning 25 countries and 2,300 patients

Rumor: Pfizer offered to buy AstraZeneca

The rumored $101 billion bid would give Pfizer a foothold in imuno-oncology and diabetes.